This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: The State University of New York, Other. Active years: 2004-2012.
Company Filing History:

Years Active: 2004-2012
Title: Libuse Anna Bobek: Innovator in Tissue Engineering and Antimicrobial Peptides
Introduction
Libuse Anna Bobek is a prominent inventor based in Williamsville, NY (US). She has made significant contributions to the fields of tissue engineering and antimicrobial agents, holding a total of 3 patents. Her innovative work focuses on developing biocompatible materials and peptides that have practical applications in medicine.
Latest Patents
One of her latest patents is titled "Tissue implants and methods for making and using same." This invention provides biocompatible, biodegradable calcium sulfate matrices containing calcium sulfate activated platelets for use in tissue formation. The matrices are particularly useful in stimulating hard tissue, such as bone formation. Additionally, these matrices may include a growth factor and/or a transfectable gene, which can be beneficial in promoting the growth of the desired tissue.
Another notable patent is for "D-isomers of antimicrobial peptide." This invention presents D-isomers of the MUC7-12-mer peptide derived from human saliva MUC7. The D-isomers exhibit antimicrobial activity comparable to that of the L-isomers and are resistant to proteolysis. These peptides can serve as effective antifungal and antimicrobial agents.
Career Highlights
Libuse Anna Bobek has worked at the State University of New York, where she has contributed to various research initiatives. Her work has been instrumental in advancing the understanding and application of tissue engineering and antimicrobial peptides.
Collaborations
Throughout her career, Libuse has collaborated with notable professionals in her field, including Giuseppe Intini and Sebastiano Andreana. These collaborations have further enriched her research and innovation efforts.
Conclusion
Libuse Anna Bobek is a trailblazer in the fields of tissue engineering and antimicrobial peptides. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving health outcomes.